Evidence map›Paper›PMID 34006872›Full record

ArticleNature communications2021

Nuclear organisation and replication timing are coupled through RIF1-PP1 interaction.

Stefano Gnan, Ilya M Flyamer, Kyle N Klein, Eleonora Castelli, Alexander Rapp, Andreas Maiser, Naiming Chen, Patrick Weber, Elin Enervald, M Cristina Cardoso and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The genome in space and time comes of age.Nucleus (Austin, Tex.) · 2024
    Article
  16. Article
  17. Dynamics of Replication-Associated Protein Levels through the Cell Cycle.International journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 7 countries.

Stefano GnanEpigenetics & Neurobiology Unit, European Molecular Biology Laboratory (EMBL Rome), Monterotondo, Italy.ORCID http://orcid.org/0000-0003-3314-4302
Ilya M Flyamer *MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Kyle N Klein *Department of Biological Science, Florida State University, Tallahassee, FL, USA.ORCID http://orcid.org/0000-0002-7713-2787
Eleonora CastelliInstitute of Cell Biology, School of Biological Sciences University of Edinburgh, Edinburgh, UK.
Alexander RappCell Biology and Epigenetics, Department of Biology, Technical University of Darmstadt, Darmstadt, Germany.ORCID http://orcid.org/0000-0001-9108-3929
Andreas MaiserDepartment of Biology II, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-2349-5822
Naiming ChenInstitute of Cell Biology, School of Biological Sciences University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2350-7627
Patrick WeberCell Biology and Epigenetics, Department of Biology, Technical University of Darmstadt, Darmstadt, Germany.
Elin EnervaldEpigenetics & Neurobiology Unit, European Molecular Biology Laboratory (EMBL Rome), Monterotondo, Italy.
M Cristina CardosoCell Biology and Epigenetics, Department of Biology, Technical University of Darmstadt, Darmstadt, Germany.ORCID http://orcid.org/0000-0001-8427-8859
Wendy A BickmoreMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-6660-7735
David M GilbertDepartment of Biological Science, Florida State University, Tallahassee, FL, USA.ORCID http://orcid.org/0000-0001-8087-9737
Sara C B BuonomoEpigenetics & Neurobiology Unit, European Molecular Biology Laboratory (EMBL Rome), Monterotondo, Italy. sara.buonomo@ed.ac.uk.ORCID http://orcid.org/0000-0002-0177-2884
Technische Universität Darmstadt · DEFlorida State University · USInstitute of Genetics and Cancer · GBCentre National de la Recherche Scientifique · FREuropean Molecular Biology Laboratory · ITFriedrich Miescher Institute · CHLMU Klinikum · DEStockholm University · SEUniversity of Edinburgh · GB

Funding

Genome Plasticity during ES Cell Differentiation to Neural LineagesR01GM083337 · NIGMS · SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE · PI David M Gilbert · 2007 to 2026
$6.1M
Medical Research Council MC_UU_00007/2NIGMS NIH HHS R01 GM083337
6 · The paper itself

Abstract

Three-dimensional genome organisation and replication timing are known to be correlated, however, it remains unknown whether nuclear architecture overall plays an instructive role in the replication-timing programme and, if so, how. Here we demonstrate that RIF1 is a molecular hub that co-regulates both processes. Both nuclear organisation and replication timing depend upon the interaction between RIF1 and PP1. However, whereas nuclear architecture requires the full complement of RIF1 and its interaction with PP1, replication timing is not sensitive to RIF1 dosage. The role of RIF1 in replication timing also extends beyond its interaction with PP1. Availing of this separation-of-function approach, we have therefore identified in RIF1 dual function the molecular bases of the co-dependency of the replication-timing programme and nuclear architecture.

Indexed as

AnimalsCell CycleCell NucleusCells, CulturedDNA Replication TimingGene ExpressionHumansMiceMice, KnockoutMice, TransgenicMouse Embryonic Stem CellsProtein BindingProtein Phosphatase 1Telomere-Binding ProteinsProtein Phosphatase 1Rif1 protein, mouseTelomere-Binding Proteins

Identifiers

PMID34006872
PMCPMC8131703
OpenAlexW3160228726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.